An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants
Condition: Cystic Fibrosis Interventions: Drug: Vanzacaftor; Drug: Vanzacaftor Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin Placebo Sponsor: Vertex Pharmaceuticals Incorporated Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2023 Category: Research Source Type: clinical trials